Lehmann A
There are ways to manage it and keep your locks looking their best
That said, not all peptides are created equal
de Sousa RAL (2022) Reactive gliosis in Alzheimers disease: a crucial role for cognitive impairment and memory loss
Response: Although we acknowledge the applicant's concerns regarding the descriptor for C1739, we do not agree that the device category code should be withdrawn and replaced with a new code effective January 1, 2026, for the following reasons: First, per the applicant's request prior to CY 2026 rulemaking, CMS revised the descriptor for C1739 to read, effective October 1, 2025: Tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system
(PubMed) Del Parigi A, Panza F, Capurso C, Solfrizzi V